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ATR–Chk1 Pathway Inhibition Promotes Apoptosis
after UV Treatment in Primary Human Keratinocytes:
Potential Basis for the UV Protective Effects of Caffeine
Timothy P. Heffernan1,5,6, Masaoki Kawasumi1,6,7, Alessandra Blasina2, Kenna Anderes2,8, Allan H. Conney3
and Paul Nghiem1,4,7
New approaches to prevent and reverse UV damage are needed to combat rising sunlight-induced skin cancer
rates. Mouse studies have shown that oral or topical caffeine promotes elimination of UV-damaged
keratinocytes through apoptosis and markedly inhibits subsequent skin cancer development. This potentially
important therapeutic effect has not been studied in human skin cells. Here, we use primary human
keratinocytes to examine which of several caffeine effects mediates this process. In these cells, caffeine more
than doubled apoptosis after 75mJ cm2 of ultraviolet light B (UVB). Selectively targeting two of caffeine’s
known effects did not alter UVB-induced apoptosis: inhibition of ataxia–telangiectasia mutated and
augmentation of cyclic AMP levels. In contrast, siRNA against ataxia-telangiectasia and Rad3-related (ATR)
doubled apoptosis after UV through a p53-independent mechanism. Caffeine did not further augment
apoptosis after UVB in cells in which ATR had been specifically depleted, suggesting that a key target of caffeine
in this effect is ATR. Inhibition of a central ATR target, checkpoint kinase 1 (Chk1), through siRNA or a new and
highly specific inhibitor (PF610666) also augmented UVB-induced apoptosis. These data suggest that a relevant
target of caffeine is the ATR–Chk1 pathway and that inhibiting ATR or Chk1 might have promise in preventing or
reversing UV damage.
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INTRODUCTION
Nonmelanoma skin cancer is the most common form of
cancer in humans, with an annual incidence of over one
million new cases in the United States. Epidemiological and
molecular studies suggest that exposure to UV light is the
most important etiological factor (Brash et al., 2008). With an
increase in recreational sun exposure, the use of UV tanning
beds, and deterioration of the ozone layer, the incidence of
nonmelanoma skin cancer is expected to increase. There is
thus a need to identify and develop new approaches to target
UV-induced skin cancers.
Much of the mutagenic and carcinogenic effects of UV
radiation are a consequence of DNA damage in the form of
cyclobutane pyrimidine dimers and 6-4 pyrimidine-pyrimi-
done photoproducts (Brash et al., 2008). UV exposure
activates diverse cellular responses in human cells, including
cell cycle arrest, DNA repair, and apoptosis. To ameliorate
the effects of UV radiation, cells rely on an intricate network
of signal transduction pathways known as cell cycle
checkpoints. Cell cycle checkpoints are biochemical surveil-
lance pathways that arrest cell cycle progression pending the
completion of essential events and/or the repair of damaged
DNA (Sancar et al., 2004). By coordinating cell cycle
progression with DNA repair, cell cycle checkpoints help to
maintain genetic stability and prevent carcinogenesis (Abra-
ham, 2001). However, recent studies have suggested that cell
cycle checkpoints that are operational in cancer cells may
reduce the effectiveness of many chemotherapeutic agents
that function by inducing DNA damage (Zhou and Bartek,
2004). Indeed, chemical or genetic inhibition of cell cycle
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checkpoint function sensitizes cancer cells to a wide variety
of DNA-damaging agents, including UV (Nghiem et al.,
2001), ionizing radiation (Syljuasen et al., 2004), alkylating
agents (Bunch and Eastman, 1996), and topoisomerase
inhibitors (Shao et al., 1997).
In humans, consumption of coffee or tea is associated with
lower incidences of nonmelanoma skin cancers in several
epidemiological studies (Jacobsen et al., 1986; Hakim et al.,
2000; Abel et al., 2007; Rees et al., 2007). In a recent study of
93,676 Caucasian women, each additional cup of caffeinated
coffee ingested was associated with a 5% decreased risk of
developing nonmelanoma skin cancer, whereas drinking
decaffeinated coffee showed no such benefit (Abel et al.,
2007). These studies imply that caffeine, one of the shared
constituents of coffee and tea, might inhibit skin carcinogen-
esis in humans. To examine this possibility, the inhibitory
effect of these beverages on skin carcinogenesis has been
investigated in mice. Indeed, oral administration of regular
tea but not decaffeinated tea was found to protect mice from
UV carcinogenesis, which led to subsequent direct tests of
caffeine’s effects on this process (Huang et al., 1997; Lou
et al., 1999). Hairless mice treated with UV twice weekly for
20 weeks had normal-appearing skin, but were at a higher
risk for developing subsequent papillomas, keratoacantho-
mas, and squamous cell carcinomas (Lou et al., 1999; Lu
et al., 2002b). This animal model resembles humans that are
chronically exposed to UV early in life and have an increased
risk of developing skin cancer later in life. Using this model,
Conney and colleagues (Lou et al., 1999; Lu et al., 2002b)
have shown that caffeine, when administered orally or
topically, inhibits tumor formation in these high-risk mice.
One potential mechanism for the inhibitory effect of
caffeine is the induction of apoptosis in UV-damaged
keratinocytes. Importantly, even long after completion of
UV exposure, topical application of caffeine selectively
induced apoptosis in nonmalignant tumors and squamous
cell carcinomas without affecting neighboring ‘‘normal’’ non-
tumor mouse skin (Lu et al., 2002b). Moreover, the effect of
caffeine does not require p53, as p53 mutant patches of
keratinocytes were selectively killed upon topical application
of caffeine (Lu et al., 2005b). Although caffeine is a known
inhibitor of cAMP phosphodiesterase (Butcher and Suther-
land, 1962), the inhibition of ataxia–telangiectasia mutated
(ATM) kinase and in particular ataxia–telangiectasia and
Rad3-related (ATR) kinase (Blasina et al., 1999; Sarkaria
et al., 1999) might account for the observed effects of caffeine
in the hairless mouse model (Lu et al., 2008).
The response to UV in human keratinocytes (HKC) is
significantly different from that of other cell types that are
more easily grown and more widely used in UV studies
(D’Errico et al., 2003, 2005) as detailed in the Discussion.
Therefore, it is important to investigate the response to UV in
HKC, the relevant cellular target for UV-induced skin
cancers. In addition, it is important to use the physiologically
relevant wavelengths of UV (ultraviolet light B (UVB),
290–320 nm), which penetrate the atmosphere and are the
major carcinogenic wavelengths of the light spectrum.
The goals of this study were to test the effect of caffeine on
UVB-irradiated HKC and to determine the target of caffeine
in this response.
We found that caffeine indeed augments UVB-induced
apoptosis in primary cultures of HKC. We show that the
relevant mechanism of caffeine is not likely to be its
inhibitory effect on cAMP phosphodiesterase because a
cell-permeable analog of cAMP had no effect on UVB-
induced apoptosis. Instead, we found that the ATR–check-
point kinase 1 (Chk1) pathway is the probable target of
caffeine in this response because inhibition of ATR or Chk1
each phenocopied the effect of caffeine and augmented
UVB-induced apoptosis in HKC. Consistent with the
observed effects of caffeine in the mouse, we found that
replication checkpoint inhibition in primary HKC augmented
cell death in a p53-independent manner. To our knowledge,
these are the first data to show that primary HKC are
sensitized to apoptosis by ATR pathway inhibition and also
the most detailed dissection of the mechanism by which
caffeine eliminates UV-damaged cells.
RESULTS
Caffeine augments UVB-induced apoptosis in HKC
Treatment of primary HKC with 75mJ cm2 of UVB induced
an apoptotic phenotype within 8 hours, including cleavage of
caspase 3 (Figure 1a and Figure S1a). Additionally, UVB
induced an increase in poly(adenosine diphosphate-ribose)
polymerase (PARP) cleavage, a response that is dependent on
caspase activation and the induction of apoptosis. Consistent
with the activation of caspase 3, propidium iodide (Figure 1b
and Figure S1b) and annexin V (Figure S1c) staining of UVB-
treated HKC showed an increase in the percentage of cells
undergoing apoptosis. Taken together, activation of
the caspase cascade and an increase in the percentage of
cells with fragmented DNA suggests that UVB induces
apoptosis in HKC.
To investigate the effect of caffeine on the response of
HKC to UVB, cells were treated with 2mM caffeine
30minutes before irradiation with UVB. Treatment with
caffeine augmented UVB-induced cleavage of caspase 3 and
PARP (Figure 1a). Using flow cytometry to quantitate
apoptotic cells, the proportion of cells undergoing apoptosis
increased from 10% in the UVB-treated keratinocytes to 24%
in cells treated with caffeine (Figure 1b). Although the
absolute number of cells undergoing UVB-induced apoptosis
varied depending on the growth characteristics of the HKC
culture (in particular, the passage number), we observed a
reproducible two- to threefold increase in apoptosis when
cells were pretreated with caffeine (Figure 1c).
To better understand the mechanism of the observed
caffeine effect, we investigated the contribution of several
known mechanisms of action for caffeine. Caffeine is an
inhibitor of cAMP phosphodiesterase (IC50¼3mM) (Butcher
and Sutherland, 1962) and thus effectively increases levels of
cAMP in cells. To determine if elevated levels of intracellular
cAMP could phenocopy the observed effects of caffeine,
HKC were pretreated with varying doses of dibutyryl cAMP, a
cell-permeable analog of cAMP. Whereas caffeine augmen-
ted UVB-induced apoptosis in HKC, doses of dibutyryl cAMP
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up to 300mM had no effect (Figure 1d). It is highly likely that
the effect of caffeine on apoptosis is not dependent on cAMP
because processes that are cAMP dependent can typically be
mimicked by significantly lower concentrations of dibutyryl
cAMP (typically o100mM) (Wang et al., 2006b). These data
suggest that caffeine augments UVB-induced apoptosis in
HKC through a separate mechanism than cAMP augmenta-
tion through phosphodiesterase inhibition.
ATR siRNA mimics caffeine: inhibition of Chk1 phosphorylation
and augmentation of apoptosis after UV treatment
To investigate whether caffeine inhibits ATR function in HKC
following UVB treatment, we examined the phosphorylation
of the ATR-dependent serine 345 residue of Chk1 in the
presence and absence of caffeine. Indeed, treatment with
2mM caffeine inhibited UVB-induced Chk1 phosphorylation
at serine 345 (Figure 2a), suggesting that caffeine inhibits ATR
under these conditions. To investigate a possible role for ATR
in the response to UVB in HKC, we used siRNA to inhibit
ATR expression. Keratinocytes were electroporated with
siRNA against ATR or a nontargeting/scrambled control and
treated with UVB 48hours later. siRNA against ATR reduced
the abundance of ATR protein by 490% and interfered with
ATR signaling as judged by marked attenuation of UVB-
induced Chk1 phosphorylation (Figure 2b). Knockdown of
ATR phenocopied the effects of caffeine in HKC and
augmented the UVB-induced increase in caspase 3 and
PARP cleavage (Figure 2b). To determine if the observed
caffeine effect was through ATR inhibition, we treated ATR
siRNA-electroporated HKC with medium or 2mM caffeine as
shown in Figure 2c. UVB treatment of HKC in which ATR had
been inhibited by siRNA induced 50% apoptosis. However,
there was no additive effect of caffeine on ATR-inhibited HKC
(50% without caffeine, 48% with caffeine). The modest
difference observed from 42% with caffeine alone to 48%
with caffeine plus ATR-siRNA can be attributed to the more
effective inhibition of ATR signaling through siRNA as
compared with chemical inhibition by 2mM caffeine
(compare p-Chk1–Ser345 in Figure 2a and b at 1 hour time
point). The lack of an additive effect of caffeine treatment on
ATR siRNA-treated HKC suggests that the majority of the
caffeine effect under these conditions is through ATR
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Figure 1. Caffeine augments UVB-induced apoptosis in human keratinocytes (HKC). (a–c) HKC were treated with vehicle (medium) or 2mM of caffeine
30minutes before 75mJ cm2 of UVB irradiation. (a) Western blots using the indicated antibodies. Cells were harvested 8 hours after UVB irradiation.
(b) Percentage of sub-2N DNA content measured by flow cytometry. Cells were harvested 24hours after UVB irradiation and stained with propidium iodide.
(c) Relative cell death was calculated by comparing percentage of sub-2N DNA content in caffeine/UVB-treated cells with that in medium/UVB-treated cells in
each experiment. Average of relative cell death is shown (n¼ 4). Error bar, standard error of the mean. (d) Percentage of sub-2N DNA content measured by flow
cytometry. HKC were treated with caffeine (Caf) or dibutyryl cyclic AMP (db-cAMP) at the indicated doses 30minutes before 75mJ cm2 of UVB irradiation.
Cells were harvested 24hours after UVB irradiation and stained with propidium iodide.
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inhibition. Taken together, these data suggest that ATR is
involved in the response to UVB in HKC and is a relevant
target of caffeine.
ATM inhibition does not augment UVB-induced apoptosis
Caffeine inhibits not only ATR, but also ATM even more
potently (IC50 for ATM¼ 0.2mM, IC50 for ATR¼1.1mM)
(Sarkaria et al., 1999). The fact that caffeine addition did not
further increase UVB-induced apoptosis in HKC depleted of
ATR by siRNA suggests that ATM is not involved in this UV-
apoptosis pathway (Figure 2c and d). In addition, we depleted
cells of ATM and/or ATR using siRNA to further investigate a
possible role for ATM in this pathway. Knockdown of
each protein kinase was monitored by western blot analysis
(Figure 3a). Consistent with the findings in Figure 2, ATR
knockdown once again potentiated the apoptotic effect of
UVB (Figure 3). By targeting ATM with siRNA, protein
expression was suppressed by roughly 70%, and the
induction by UVB of active ATM (phospho-Serine 1981
ATM) was inhibited by roughly 50% (Figure S2). siRNA
against ATM did not affect damage-induced phosphorylation
of Thr-68 on Chk2 (a known target of ATM), but ATR is
known to compensate for ATM in this process (Helt et al.,
2005; Wang et al., 2006a). Indeed, double knockdown of
ATM and ATR showed a marked suppression of Chk2
phosphorylation, suggesting that ATM function was signifi-
cantly inhibited by siRNA in these cells (Figure S2). In no
case, however, did the addition of siRNA against ATM affect
UVB-induced apoptosis (Figure 3b and c). Taken together,
these data suggest that ATM is not the relevant target of
caffeine for this process in HKC.
Genetic and chemical inhibition of Chk1 augments
UVB-induced apoptosis
In response to DNA damage, ATR mediates much of its
checkpoint signaling through its downstream effector kinase
Chk1. To investigate whether or not Chk1 inhibition would
potentiate UVB-induced apoptosis in HKC, we abrogated
Chk1 function both genetically and chemically. Electropora-
tion of HKC with siRNA directed against Chk1 reduced
protein expression by nearly 90% (Figure 4a). HKC with
reduced expression of Chk1 were significantly sensitized to
apoptosis induced by UVB (Figure 4a); however, Chk1
inhibition by siRNA did not augment UVB-induced apoptosis
to the same degree as caffeine or ATR siRNA. We observed a
60% increase in cell death when comparing siRNA against
Chk1 to scrambled siRNA controls.
Chemical inhibition of Chk1 has typically been carried out
with UCN-01, originally identified as an inhibitor of protein
kinase C (Wang et al., 1996; Busby et al., 2000). UCN-01 has
 UVB 
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Figure 2. ATR siRNA mimics caffeine: inhibition of Chk1 phosphorylation and augmentation of apoptosis after UV treatment. (a) Western blots using the
indicated antibodies. Human keratinocytes (HKC) were treated with vehicle (medium) or 2mM of caffeine 30minutes before 75mJ cm2 of UVB irradiation.
Cells were harvested 2 hours after UVB irradiation. (b–d) HKC were electroporated with siRNA against ATR or a nontargeting/scrambled control (scr). Forty-eight
hours later, cells were exposed to 75mJ cm2 of UVB. (b) Western blots using the indicated antibodies. Cells were harvested 1 or 8 hours after UVB irradiation as
indicated. (c) Percentage of sub-2N DNA content measured by flow cytometry. Cells were treated with vehicle (medium) or 2mM of caffeine 30minutes before
UVB irradiation. Cells were harvested 24hours after UVB irradiation and stained with propidium iodide. (d) Relative cell death was calculated by comparing
percentage of sub-2N DNA content in scrþ caffeine/UVB-, ATRþmedium/UVB-, or ATRþ caffeine/UVB-treated cells with that in scrþmedium/UVB-treated
cells in each experiment. Average of relative cell death is shown (n¼ 3). Error bar, standard error of the mean.
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been shown to have inhibitory effects toward several protein
kinases, including Chk1, protein kinase C, and cyclin-
dependent kinases (CDKs). Thus a major effort in the field
is to generate more selective Chk1 inhibitors. Here, we
describe the characteristics and first use of a potent, highly
selective Chk1 inhibitor, PF610666 (Figure 4b). The docking
pose of PF610666 with the Chk1 enzyme (Figure 4b) was
obtained by modifying the Chk1 cocrystal structure (Chen
et al., 2000) with PF279192, which differs only by a halogen
atom that does not contact the active site (a chloride in
PF610666 and a bromide in PF279192). The compound
binds to the ATP-binding pocket through hydrogen bonds
with Cys87 and Glu85 in the hinge region (Figure 4b, white
asterisk on left). The phenylbutanamide tail (Figure 4b, white
asterisk on right) is immediately adjacent to the key catalytic
residue Asp148. In this manner, PF610666 prevents
Chk1 from phosphorylating its protein substrates. The
inhibitory effect of PF610666 was tested against a panel
of human kinases and shown to be highly selective against
Chk1 (IC50¼7 nM; Table 1). Effective concentration 50
(EC50) of PF610666 for cellular activity measured as the
ability to override the camptothecin-induced checkpoint
was 70 nM.
To complement our genetic studies, we treated HKC with
varying doses of PF610666. Treatment of HKC with PF610666
augmented UVB-induced PARP cleavage at 8hours (Figure 4c)
and increased the percentage of cells with sub-2N DNA
content at 24hours (Figure 4d). Taken together, genetic and
chemical inhibition of Chk1 could each phenocopy the effect
of caffeine and of ATR inhibition, providing further support for
the importance of this pathway in the UV response and in the
effect of caffeine on this response.
ATR-induced apoptosis is largely p53 independent in HKC
p53 is frequently mutated in nonmelanoma skin cancers, and
therapies that induce apoptosis independent of p53 are of
great interest. To investigate the contribution of p53 in the
response of HKC to UVB, we inhibited p53 expression using
siRNA. HKC were electroporated with siRNA against p53
and/or ATR, and then UV-irradiated 48 hours later
(Figure 5a). Treatment of HKC with 75mJ cm2 UVB strongly
induced p53 protein levels at 8 hours. Knockdown of p53 not
only blocked this induction, but also suppressed p53 protein
levels below the pre-UVB treatment baseline (Figure 5a). As
in the previous experiments, knockdown of ATR markedly
augmented the number of HKC that underwent UVB-induced
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of the mean.
www.jidonline.org 1809
TP Heffernan et al.
Caffeine, ATR, and UV-Induced Apoptosis in HKC
apoptosis (Figure 5b and c). Blocking p53 protein induction,
however, had no effect on UVB-induced apoptosis in HKC
and only modestly reduced the ability of ATR inhibition to
augment apoptosis.
DISCUSSION
In this study, we have used the relevant primary human cell
type to examine the mechanism by which caffeine affects the
response to UV. We found that genetic or chemical inhibition
of the ATR–Chk1 pathway augmented UVB-induced apopto-
sis in a largely p53-independent manner in HKC. In contrast,
other known and plausible targets of caffeine were not
involved in the UV response, including ATM and the
regulation of cAMP levels. Our finding that cAMP levels
were not involved in UV signaling in HKC agrees well with a
previous study that concluded that augmenting cAMP does
not mimic the effects of caffeine on lowering UV-induced
carcinogenesis in mouse skin (Zajdela and Latarjet, 1978).
The effects of caffeine on skin cancer are of interest due to
human epidemiological studies linking coffee and tea
consumption with lower rates of nonmelanoma skin cancer
(Jacobsen et al., 1986; Hakim et al., 2000; Abel et al., 2007;
Rees et al., 2007), as well as animal studies showing that
caffeine inhibits tumor formation in mice chronically treated
with UV (Zajdela and Latarjet, 1978; Huang et al., 1997; Lu
et al., 2002b). We have shown previously that topical
caffeine application to mouse skin after a single dose of
UVB augmented the number of apoptotic keratinocytes as
evaluated by sunburn cell formation and other markers of
programmed cell death (Lu et al., 2002a; Koo et al., 2007).
These findings suggest that topical application of caffeine to
mouse skin after UV irradiation augments the deletion of
DNA-damaged keratinocytes, and may provide protection
from UV-induced skin cancer development.
Nonmelanoma skin cancers arise through the transforma-
tion of keratinocytes induced by UV. Thus, it is important to
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investigate the cellular responses to UVB in the relevant cell
type that gives rise to UV-induced skin cancers. A recent
study comparing primary HKC and dermal fibroblasts showed
that keratinocytes are far more susceptible to UVB-induced
apoptosis than fibroblasts; yet they are more UVB-resistant
than fibroblasts in terms of their proliferative ability as
measured by colony survival assays (D’Errico et al., 2003).
Moreover, keratinocytes have a greater ability (through robust
global genome repair) for UV-DNA repair than fibroblasts, as
might be expected from cells that are ‘‘professional’’ UV-
responsive cells (D’Errico et al., 2005). Indeed, we found that
caffeine markedly augmented UVB-induced apoptosis in
HKC (Figure 1). This finding suggests that the promotion of
UVB-apoptosis by caffeine described in mouse keratinocytes
also occurs in human primary keratinocytes.
Caffeine concentration is an important issue when compar-
ing studies in mice and humans. Oral administration of caffeine
as drinking fluid (0.4mgml1) inhibits UV-induced skin
carcinogenesis in mice (Huang et al., 1997). The plasma and
epidermal concentrations of caffeine in mice receiving the
cancer-preventive dose of caffeine in drinking water
(0.4mgml1, 2mM) is 16mM and 16nmol g1 tissue, respec-
tively, on average in a 24-hour period (Conney et al., 2007).
The observed plasma concentration of caffeine in mice is
consistent with the plasma concentration in humans
(3.2mg l1, 16mM) drinking 2–5 cups of coffee per day
(de Leon et al., 2003). Recently, Conney and colleagues
(Lu et al., 2008) showed that caffeine administered
orally (0.4mgml1, 2mM) with drinking water markedly
inhibited the UVB-induced phosphorylation of Chk1 on
Ser345 in the epidermis of mice. As Ser345 phosphorylation
of Chk1 has been shown to be highly dependent on
ATR function, this means that, in vivo in the mouse,
plasma concentrations of 16mM appear to be sufficient to
inhibit ATR function in keratinocytes. Our in vitro studies using
keratinocytes are similar to other studies using cells in culture
in which effective ATR inhibition requires caffeine doses closer
to those required in cell-free in vitro kinase assays where the
IC50 against ATR is 1.1mM for caffeine (Sarkaria et al., 1999).
These differences in the ability of caffeine to inhibit ATR
function in vitro versus in vivo have yet to be explained but
may be related to the nonphysiological conditions that are
required to initiate ATR activity in vitro (Sarkaria et al., 1999).
We also investigated the involvement of Chk1, which is
phosphorylated by ATR in response to UV. These experi-
ments were carried out because, if ATR is the relevant target
of caffeine, its effects would most likely be mediated by Chk1
and also because previously unknown specific Chk1 inhibi-
tors are on the horizon for human therapy. UV irradiation
induced phosphorylation of Chk1 maximally at 1 hour,
and the phosphorylation signal was nearly lost by 8 hours
(Figure 2b and Figure S1a). Similar Chk1 phosphorylation
kinetics have been observed in a recent study and attributed
to PPM1D, a serine/threonine phosphatase, whose expression
is transcriptionally induced shortly after UV irradiation, and
which dephosphorylates phospho-Chk1 at later time points
(8 hours or later post-UV) (Lu et al., 2005a).
Augmentation of UVB-induced apoptosis by siRNA
against Chk1 (Figure 4a) was not as robust as that by siRNA
against ATR (Figure 2d). A possible explanation is that
incomplete Chk1 knockdown by siRNA allowed sufficient
Chk1 function to partially activate the checkpoint. Another
possibility is that ATR targets other than Chk1 also play a role
in UV-induced apoptosis, and ATR knockdown suppresses
their function as well as the function of Chk1. Similarly, Chk1
knockdown was not as strong as 1mM PF610666 (Figure 4d) in
augmenting UVB-induced apoptosis, and this may also be
due to more effective inhibition of Chk1 by PF610666 or by
this compound inhibiting kinases in addition to Chk1 (Chk2
and other kinases are partially inhibited in vitro at this
concentration of PF610666; Table 1).
Pharmacological inhibition of Chk1 has been extensively
used to study the contribution of Chk1 in the cellular
responses to DNA damage. UCN-01, originally identified as
an inhibitor of protein kinase C, has been shown to be a
potent Chk1 inhibitor (Wang et al., 1996; Busby et al., 2000).
Studies have shown that UCN-01 abrogates Chk1-dependent
cellular responses and sensitizes cancer cells to several DNA-
damaging agents, including mitomycin C (Akinaga et al.,
1993), cisplatin (Bunch and Eastman, 1996), camptothecin
(Shao et al., 1997), and 5-fluorouracil (Hsueh et al., 1998).
Owing to the known off-target inhibitory effects (that is,
Table 1. IC50 values of PF610666 and UCN-01 for
selected kinases
IC50 (nM)
Kinase analyzed PF610666 UCN-01
CHK1 7 11
CHK2 41,000 1,040
CDK1 41,000 31
CDK2 41,000 30
PKC 41,000 7
RAF 41,000 620
JNK 41,000 ND
MEK1 41,000 ND
PLK3 41,000 ND
mTOR 41,000 ND
CDK, cyclin-dependent kinase; CHK, checkpoint kinase; JNK, c-Jun N-
terminal kinase; MEK1, mitogen activated protein kinase/extracellular
signal-regulated kinase kinase-1; mTOR, mammalian target of rapamycin;
ND, not determined; PKC, protein kinase C; PLK3, polo-like kinase 3.
The concentration of the indicated compound at which the maximum
in vitro activity of the indicated kinase has been inhibited to 50% (IC50) is
shown in nM. IC50 values for PF610666 were determined as described in
‘‘Materials and Methods’’. IC50 values for UCN-01 were obtained from
previous studies (Kawakami et al., 1996; Busby et al., 2000).
‘‘IC5041,000 nM’’ means that the kinase inhibition was less than 50%
at 1,000 nM.
The fraction of maximum in vitro kinase activity that was inhibited for
each of the following kinases in the presence of 1 mM PF610666 is listed
below (‘‘100%’’ means kinase activity was entirely blocked by 1 mM of the
compound): 100% for Chk1, 38% for Chk2, 14% for Raf, and less than
10% for each of these kinases: CDK1, CDK2, PKC, JNK, MEK1, PLK3, and
mTOR.
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protein kinase C and CDKs) of UCN-01 (Kawakami et al.,
1996; Busby et al., 2000) and an interest in therapeutic
applications for Chk1 inhibition, previously unknown in-
hibitors of this kinase have been developed. Here, we show
that a newly developed compound that is far more selective
than UCN-01 for Chk1 inhibition (Table 1) potently
augmented UVB-induced apoptosis (Figure 4c and d). The
ability of this compound to potentiate the effects of DNA
damage has led to the development of its sister compound as
a cancer therapeutic (Blasina et al., 2008).
Previous studies in human cancer cell lines (Nghiem et al.,
2001) and mouse skin (Lu et al., 2004, 2005b) have shown
that p53 disruption sensitizes cells to inhibition of ATR. In
contrast, we found that p53 knockdown did not augment
UVB-induced apoptosis by ATR inhibition in HKC (Figure 5b
and c). This discrepancy might be explained by one or more
of the following possibilities: (i) apoptosis-signaling mechan-
isms may differ between these cell types; (ii) differences in
methodology—p53 expression itself was suppressed in this
study, whereas p53 function was disrupted through over-
expression of MDM2 or E6 in the human cancer cell line
study. What is clear and in agreement between these studies
is that the majority of the apoptosis augmentation by ATR
inhibition is p53 independent.
Normal human skin carries clonal patches of p53-mutated
keratinocytes in as much as 4% of the epidermis representing
thousands of such clones per person (Jonason et al., 1996). Sun
exposure increases the frequency and size of the p53-mutant
clones in skin. These findings suggest that p53-mutant clones
might be resistant to UV-induced apoptosis. There is thus a
need for a p53-independent therapy against UV-damaged
keratinocytes. Topical applications of caffeine to mice with
multiple patches of p53-mutant skin cells enhanced the
elimination of these cells in the absence of further UVB
irradiation (Lu et al., 2005b). Here, we have shown that
inhibition of the ATR–Chk1 pathway by caffeine or a selective
Chk1 inhibitor promotes culling of DNA-damaged human
primary keratinocytes regardless of p53 status. These are the
most detailed studies yet to determine the mechanism by
which caffeine augments UV apoptosis. These data suggest
that topical application of caffeine or another ATR–Chk1
pathway inhibitor, perhaps in a sunscreen or after-sun
preparation, could be investigated as an approach to minimize
or reverse the effects of UV damage in human skin.
MATERIALS AND METHODS
Cell lines and culture conditions
Normal HKC were isolated from adult abdominal epidermis harvested
from two female patients (age 37 and 66) as described previously
(Kitano and Okada, 1983; Normand and Karasek, 1995; Boswell et al.,
2007) in a protocol approved by the Massachusetts General Hospital
Institutional Review Board. Written, informed patient consent was
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Figure 5. ATR-induced apoptosis is largely p53 independent in human keratinocytes (HKC). HKC were electroporated with siRNA against ATR and/or
p53, or a nontargeting/scrambled control (scr). Forty-eight hours later, cells were exposed to 75mJ cm2 of UVB. (a) Western blots using the indicated
antibodies. Cells were harvested 8 hours after UVB irradiation. (b) Percentage of sub-2N DNA content measured by flow cytometry. Cells were harvested
24hours after UVB irradiation and stained with propidium iodide. (c) Relative cell death was calculated by comparing percentage of sub-2N DNA
content in ATR/UVB-, p53/UVB-, or ATRþ p53/UVB-treated cells with that in scr/UVB-treated cells in each experiment. Average of relative cell death is
shown (n¼ 3). Error bar, standard error of the mean.
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obtained in adherence to the Helsinki Guidelines. Briefly, fresh
specimens were washed in phosphate-buffered saline (PBS) and
disinfected with 70% ethanol. After removing adipose and dermal
tissue, the remaining skin was digested in dispase solution (Hanks’
balanced salt solution (Invitrogen, Carlsbad, CA) containing 10mM
HEPES, 0.075% sodium bicarbonate, and 50mgml1 gentamicin
mixed 1:1 with Dispase II solution (Roche, Indianapolis, IN)) at 41C
for 18hours. The epidermis was then peeled off and trypsinized to
isolate the keratinocytes, which were plated in Defined Keratinocyte-
SFM (serum-free medium) (Invitrogen) on collagen I (Inamed, Fremont,
CA)-coated plates and maintained at 371C in a humidified atmosphere
of 5% CO2. The stock culture was aliquoted, frozen, and thawed as
needed. Experiments were conducted on logarithmically growing HKC
between passages 2 and 5.
Chemicals
Caffeine (Sigma, St Louis, MO) was dissolved in PBS to a final
concentration of 100mM. Thirty minutes before UVB treatment, the
appropriate volume of caffeine was added to culture medium to a
final concentration of 2mM. N6,20-O-Dibutyryladenosine 30,50-cyclic
monophosphate sodium salt (dibutyryl cAMP) (Sigma) was dissolved
in purified water to a final concentration of 100mM. Thirty minutes
before UVB treatment, the appropriate volume of dibutyryl cAMP
was added to culture medium. PF610666 was synthesized by Pfizer
(San Diego, CA). PF610666 was dissolved in DMSO and stored at
room temperature. Thirty minutes before UVB treatment, the
appropriate volume of PF610666 or vehicle (DMSO) was added to
culture medium.
PF610666 inhibitor potency and kinase selectivity
The inhibitory potency of PF610666 against the human, recombinant
Chk1 kinase domain was determined in a biochemical activity-based
assay. Chk1 activity was measured by a pyruvate kinase-lactate
dehydrogenase coupled, continuous spectrophotometric assay where
the phosphorylation of a Chk1 peptide substrate (Syntide-2, PLARTLS-
VAGLPGKK) was coupled to the oxidation of NADH, and the
corresponding change in absorbance intensity was measured at
340nm using a SpectraMax plate reader (Molecular Devices Corp,
Sunnyvale, CA). The assay was performed in a 96-well plate for
20minutes at 301C in 0.1ml of assay buffer containing 50mM Tris pH
7.5, 0.4M NaCl, 4mM PEP, 0.15mM NADH, 28U of lactate
dehydrogenase per ml, 16U of pyruvate kinase per ml, 3mM DTT,
0.125mM Syntide-2, 0.15mM ATP, and 25mM magnesium chloride.
Assays were initiated with 1nM of Chk1 kinase domain. The inhibition
of Chk1 activity was determined by measuring initial velocities in the
presence of varying concentrations of PF610666 (Blasina et al., 2008).
The data were analyzed using Enzyme Kinetic and Excel software and
fit to a kinetic model for competitive inhibition to obtain a Ki value. The
kinase selectivity of PF610666 was evaluated by screening the
compound at 1 or 10mM against a panel of about 100 protein kinases.
These kinase selectivity screens were performed in-house at Pfizer or by
the kinase screening laboratories at Upstate/Millipore and the Division
of Signal Transduction Therapy, University of Dundee. Effective
concentration 50 (EC50) was defined as the concentration of a Chk1
inhibitor that overcame a camptothecin-induced S-phase checkpoint
and caused mitosis (as measured by histone H3 phosphorylation at
Ser10 in dot blot assay) in 50% of the cell population as compared with
a nocodazole-only treated positive control.
RNA interference
SMARTpool siRNAs were synthesized by Dharmacon (Lafayette,
CO) against human ATM, p53, and Chk1. A siRNA duplex against
human p53 was also synthesized using the following target
sequence: AAGACTCCAGTGGTAATCTAC. ATR knockdown was
accomplished using a siRNA duplex against the following target
sequence: AACCTCCGTGATGTTGCTTGA. A siCONTROL nontar-
geting siRNA (Dharmacon) was used as a nonspecific control. Cells
were electroporated by Nucleofector I Device (Amaxa, Gaithers-
burg, MD) using human dermal fibroblast nucleofector kit and
program T-24. Cells were harvested by trypsinization, resuspended
in nucleofector solution at approximately 1–4 106 cells per 100ml
of solution, transfected with 140 picomoles of siRNA, and split to the
appropriate number of collagen I-coated plates. Cells were allowed
to recover for 48 hours before treatment. Knockdown of targeted
gene products was monitored by western immunoblot analysis.
UV irradiation
Before treatment with UVB, culture medium (containing caffeine,
dibutyryl cAMP, or PF610666 as indicated) was removed and
reserved. Cultures were washed once with warm PBS and then
placed uncovered under a panel of four UVB bulbs (RPR-3000,
Southern New England Ultraviolet, Branford, CT), emitting radiation
centered around 311nm. A Kodacel filter (K6808, Eastman Kodak,
Rochester, NY) was used to eliminate any ultraviolet light C
(o290nm). Cells were exposed to 75mJ cm2 of UVB. UV dose
was monitored with a Photolight IL1400A radiometer equipped with
a SEL240/UVB detector (International Light Technologies, Peabody,
MA). Following irradiation, the reserved medium was replaced, and
the cultures were incubated for the indicated periods of time. Sham-
treated cultures were handled exactly the same way, except that they
were not exposed to UVB.
Western immunoblot analyses
Cells were harvested by trypsinization, washed once in PBS, and
resuspended in RIPA (10mM Tris-HCl (pH 7.4), 150mM NaCl, 1mM
EDTA, 1%Nonidet P-40, 0.25%Na-deoxycholate) supplemented with
Complete Protease Inhibitor Cocktail (Roche). After clarifying the
extract by centrifugation, protein concentration was determined using
the Bradford Assay Reagent (Bio-Rad, Hercules, CA). Samples
containing equal amounts of protein were mixed with 4 NuPAGE
lithium dodecyl sulfate sample buffer (Invitrogen) containing 5% b-
mercaptoethanol, boiled, and separated by SDS-PAGE. Proteins were
transferred to polyvinylidene difluoride membrane and probed with
antibodies against Chk1 (G-4), actin (I-19) (both from Santa Cruz
Biotechnology, Santa Cruz, CA); Chk2 (Ab-1) (NeoMarkers, Fremont,
CA); p53 (1C12), phospho-Chk1 (Ser345) (133D3), phospho-Chk2
(Thr68), phospho-ATM (Ser1981) (10H11.E12), cleaved PARP
(Asp214) (19F4), cleaved caspase-3 (Asp175) (5A1) (all from Cell
Signaling Technology, Danvers, MA); GAPDH (ab9485) (Abcam,
Cambridge, MA); ATM (2C1) (GeneTex, San Antonio, TX), and an ATR
rabbit polyclonal antibody generated using a peptide spanning amino
acids 1–20 of human ATR (Nghiem et al., 2001).
Flow cytometry
For measuring sub-2N DNA content, cells were trypsinized and
harvested 24 hours post-UV irradiation and fixed with 70% ethanol
for 1 hour or overnight at 41C. Cells were washed once with PBS,
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treated with 1mgml1 ribonuclease A (Sigma) for 30minutes at
371C, and stained with 50 mgml1 propidium iodide (Sigma). For
measuring annexin V-positive cells, cells were stained with annexin
V-FITC (Assay Designs, Ann Arbor, MI) following the manufacturer’s
protocol. Cells were analyzed on a FACSCalibur (BD Biosciences,
San Jose, CA) or Cytomics FC 500 (Beckman Coulter, Fullerton, CA)
flow cytometer. The acquired data were analyzed using the FlowJo
6.3.4 software package (Tree Star Inc., Ashland, OR) or CXP Analysis
2.2 (Beckman Coulter).
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Figure S1. Time course of UVB-induced apoptosis in human keratinocytes.
Figure S2. ATR/ATM-dependent signaling following UVB treatment.
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